New Drug Promising Against Rheumatoid Arthritis

Related Encyclopedia • Autoimmune Diseases and Disorders • Behcet's Disease • Dermatomyositis and Polymyositis • Polymyositis and Dermatomyositis More... Related Animations • Rheumatoid Arthritis More... Related Healthscout Videos New Knee = A Leg Up for Patients Rotator Repair Eating Away Arthritis Symptoms Kicking Recovery Time! New Knee Procedure More... Related News Articles • Health Tip: Are You at Risk for Hip Bursitis? • Obesity Appears Linked to Pain • More Than 4 Million Americans Have New Knee • Health Tip: Troubled by a Toothache? More...

Page:  << Prev | 1 | 2

The study, which was funded by drug makers Centocor, Inc. and Schering- Plough, appears online June 29 inThe Lancet.

Rheumatoid arthritis is a chronic inflammatory disease that affects about 1.3 million people in the United States. TNF-a inhibitors are widely used to treat the disease, but 30 to 50 percent of patients treated with these drugs are intolerant or have an inadequate response to the drugs. Prior to this study, no controlled trials had examined whether patients who don't respond to one TNF-a inhibitor might respond to another.

More information

Text Continues Below

---

The Arthritis Foundation has more about rheumatoid arthritis.

Page:  << Prev | 1 | 2

-- Robert Preidt